Industry Educational Session - Management of mIDH AML: Practical implementation and experience- Sponsored by Servier
Tracks
-
| Monday, April 28, 2025 |
| 2:20 PM - 3:05 PM |
| Carron 2 |
Details
Join our symposium to hear a presentation on an overview of IDH mutations and the management of AML within an emerging landscape, including insights into two real world case studies. Expert speakers include Prof Steve Knapper, Dr Kath Hodby, Dr Akila Danga, and Dr Benjamin Lau. This promotional symposium is for healthcare professionals only and is organised and funded by Servier.
M-TA-UK-00071
Date of Preparation April 2025
Speaker
Katharine Hodby
Consultant Haematologist, UHBW TYA Haematology Lead, UHBW
University Hospitals Bristol and Weston NHS Foundation Trust
- Consultant Haematologist at University Hospitals Bristol & Weston Areas of interest: AML, ALL and TYA Lead
Prof. Steven Knapper
Professor In Haematology
Cardiff University
- Deputy Medical Director of the UK Trials Acceleration Programme, Joint Lead of the Cardiff CRUK Experimental Cancer Medicine Centre and Chair of the UK ECMC Haematology.
Dr. Akila Danga
Haematology Consultant
The Hillingdon Hospital NHS Foundation Trust
- Consultant Haematologist The Hillingdon Hospitals NHS Foundation Trust
Dr. Benjamin Lau
Haematologist
Imperial College London
- Haematology specialty trainee, North West London deanery. Areas of interest: haematological malignancies and diagnostics, molecular diagnostics, novel targeted therapies, applications of artificial intelligence within the diagnostic sphere.
